CONCORD DRUGS
|
CONCORD DRUGS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹45 Cr | ₹45 Cr | ₹52 Cr | ₹59 Cr |
| Sales | ₹45 Cr | ₹45 Cr | ₹52 Cr | ₹59 Cr |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - |
| Revenue from property development | - | - | - | - |
| Other Operational Income | - | - | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹45 Cr | ₹45 Cr | ₹52 Cr | ₹59 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹-2.86 Cr | ₹-3.47 Cr | ₹0.88 Cr | ₹-4.65 Cr |
| Raw Material Consumed | ₹32 Cr | ₹30 Cr | ₹28 Cr | ₹32 Cr |
| Opening Raw Materials | ₹4.74 Cr | ₹4.96 Cr | ₹5.03 Cr | ₹3.80 Cr |
| Purchases Raw Materials | ₹31 Cr | ₹30 Cr | ₹28 Cr | ₹33 Cr |
| Closing Raw Materials | ₹4.31 Cr | ₹4.74 Cr | ₹4.96 Cr | ₹5.03 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | - | - | - | - |
| Electricity & Power | - | - | - | - |
| Oil, Fuel & Natural gas | - | - | - | - |
| Coals etc | - | - | - | - |
| Other power & fuel | - | - | - | - |
| Employee Cost | ₹3.56 Cr | ₹5.00 Cr | ₹3.84 Cr | ₹4.14 Cr |
| Salaries, Wages & Bonus | ₹3.33 Cr | ₹4.81 Cr | ₹3.64 Cr | ₹3.57 Cr |
| Contributions to EPF & Pension Funds | ₹0.11 Cr | ₹0.11 Cr | ₹0.10 Cr | ₹0.38 Cr |
| Workmen and Staff Welfare Expenses | ₹0.11 Cr | ₹0.08 Cr | ₹0.10 Cr | ₹0.18 Cr |
| Other Employees Cost | - | - | - | - |
| Other Manufacturing Expenses | ₹6.71 Cr | ₹6.88 Cr | ₹13 Cr | ₹16 Cr |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | - | - | - | - |
| Repairs and Maintenance | ₹0.04 Cr | ₹0.08 Cr | ₹0.10 Cr | ₹0.08 Cr |
| Packing Material Consumed | ₹6.17 Cr | ₹6.26 Cr | ₹12 Cr | ₹15 Cr |
| Other Mfg Exp | ₹0.51 Cr | ₹0.54 Cr | ₹0.64 Cr | ₹0.55 Cr |
| General and Administration Expenses | ₹1.66 Cr | ₹1.88 Cr | ₹1.81 Cr | ₹1.30 Cr |
| Rent , Rates & Taxes | ₹0.07 Cr | ₹0.20 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Insurance | ₹0.04 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Printing and stationery | ₹0.10 Cr | ₹0.09 Cr | ₹0.14 Cr | ₹0.10 Cr |
| Professional and legal fees | ₹0.24 Cr | ₹0.30 Cr | ₹0.33 Cr | ₹0.26 Cr |
| Traveling and conveyance | ₹0.01 Cr | ₹0.04 Cr | ₹0.03 Cr | ₹0.00 Cr |
| Other Administration | ₹1.19 Cr | ₹1.20 Cr | ₹1.17 Cr | ₹0.79 Cr |
| Selling and Distribution Expenses | ₹0.02 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.01 Cr |
| Advertisement & Sales Promotion | ₹0.02 Cr | ₹0.01 Cr | ₹0.04 Cr | - |
| Sales Commissions & Incentives | - | - | - | - |
| Freight and Forwarding | - | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr |
| Handling and Clearing Charges | - | - | - | - |
| Other Selling Expenses | - | - | - | ₹0.00 Cr |
| Miscellaneous Expenses | ₹0.10 Cr | ₹0.12 Cr | ₹0.06 Cr | ₹5.19 Cr |
| Bad debts /advances written off | - | - | - | ₹5.15 Cr |
| Provision for doubtful debts | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - |
| Losson foreign exchange fluctuations | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.10 Cr | ₹0.12 Cr | ₹0.06 Cr | ₹0.04 Cr |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹41 Cr | ₹41 Cr | ₹48 Cr | ₹53 Cr |
| Operating Profit (Excl OI) | ₹4.14 Cr | ₹4.04 Cr | ₹4.57 Cr | ₹5.59 Cr |
| Other Income | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.10 Cr |
| Interest Received | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.10 Cr |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - |
| Profits on sale of Investments | - | - | - | - |
| Provision Written Back | - | - | - | - |
| Foreign Exchange Gains | - | - | - | - |
| Others | - | - | ₹0.00 Cr | ₹0.00 Cr |
| Operating Profit | ₹4.15 Cr | ₹4.05 Cr | ₹4.58 Cr | ₹5.69 Cr |
| Interest | ₹2.03 Cr | ₹1.87 Cr | ₹1.71 Cr | ₹1.68 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹1.92 Cr | ₹1.82 Cr | ₹1.63 Cr | ₹1.41 Cr |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹0.11 Cr | ₹0.05 Cr | ₹0.07 Cr | ₹0.10 Cr |
| Other Interest | - | - | - | ₹0.17 Cr |
| PBDT | ₹2.12 Cr | ₹2.18 Cr | ₹2.88 Cr | ₹4.01 Cr |
| Depreciation | ₹1.43 Cr | ₹1.56 Cr | ₹1.63 Cr | ₹1.77 Cr |
| Profit Before Taxation & Exceptional Items | ₹0.69 Cr | ₹0.63 Cr | ₹1.25 Cr | ₹2.25 Cr |
| Exceptional Income / Expenses | - | - | - | - |
| Profit Before Tax | ₹0.69 Cr | ₹0.63 Cr | ₹1.25 Cr | ₹2.25 Cr |
| Provision for Tax | ₹0.36 Cr | ₹0.16 Cr | ₹0.26 Cr | ₹0.65 Cr |
| Current Income Tax | ₹0.20 Cr | ₹0.22 Cr | ₹0.38 Cr | ₹0.67 Cr |
| Deferred Tax | ₹0.15 Cr | ₹-0.06 Cr | ₹-0.12 Cr | ₹-0.02 Cr |
| Other taxes | - | - | - | - |
| Profit After Tax | ₹0.34 Cr | ₹0.47 Cr | ₹0.99 Cr | ₹1.59 Cr |
| Extra items | - | - | - | - |
| Minority Interest | - | - | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹0.34 Cr | ₹0.47 Cr | ₹0.99 Cr | ₹1.59 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr |
| Appropriations | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | ₹0.04 Cr | ₹0.05 Cr | ₹0.09 Cr | - |
| Equity Dividend % | - | - | - | - |
| Earnings Per Share | ₹0.34 | ₹0.47 | ₹1.06 | ₹1.82 |
| Adjusted EPS | ₹0.34 | ₹0.47 | ₹1.06 | ₹1.82 |
Compare Income Statement of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹92.7 Cr | 8.9% | -2.8% | 33.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 8.9% |
-2.8% |
33.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses